7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3, 6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof

Details for Australian Patent Application No. 2006224465 (hide)

International Classifications

Event Publications

20 September 2007 PCT application entered the National Phase

PCT publication WO2006/097624 Priority application(s): WO2006/097624

13 October 2011 Application Accepted

Published as AU-B-2006224465

9 February 2012 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.